Parallax Volatility Advisers’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-33,600
Closed -$1.34M 3042
2022
Q1
$1.34M Buy
+33,600
New +$1.2M ﹤0.01% 1530
2019
Q2
Sell
-126,200
Closed -$2.03M 3032
2019
Q1
$2.03M Buy
+126,200
New +$2.04M ﹤0.01% 996
2018
Q3
Sell
-40,000
Closed -$675K 2975
2018
Q2
$675K Sell
40,000
-715,000
-95% -$13.5M ﹤0.01% 1198
2018
Q1
$14.8M Buy
755,000
+330,500
+78% +$6.4M 0.02% 302
2017
Q4
$8.6M Sell
424,500
-162,500
-28% -$2.99M 0.01% 454
2017
Q3
$10.2M Buy
587,000
+420,400
+252% +$5.69M 0.02% 404
2017
Q2
$2.14M Buy
166,600
+106,600
+178% +$1.42M ﹤0.01% 816
2017
Q1
$778K Sell
60,000
-7,500
-11% -$94.8K ﹤0.01% 1284
2016
Q4
$667K Buy
+67,500
New +$739K ﹤0.01% 1393
2016
Q3
Sell
-250,000
Closed -$2.16M 3291
2016
Q2
$2.16M Sell
250,000
-133,100
-35% -$1.31M ﹤0.01% 900
2016
Q1
$3.63M Buy
+383,100
New +$3.6M 0.01% 684
2015
Q4
Sell
-33,000
Closed -$443K 3281
2015
Q3
$443K Sell
33,000
-88,300
-73% -$1.77M ﹤0.01% 1576
2015
Q2
$2.74M Buy
+121,300
New +$2.13M 0.01% 955
2014
Q3
Sell
-40,000
Closed -$395K 4259
2014
Q2
$395K Buy
+40,000
New +$339K ﹤0.01% 1528

Other funds holding HALO

Parallax Volatility Advisers's HALO Position: Q1 2019 in Review

Parallax Volatility Advisers sold out of Halozyme (HALO) in Q1 2019, closing a stake of 8,494 shares — an estimated $138K sold.

Parallax Volatility Advisers first reported a position in HALO in Q1 2017 and held it in 3 quarters. The position peaked at $370K in Q4 2017. 201 funds tracked by Wall St. Rank hold HALO as of Q1 2019.

  • Parallax Volatility Advisers reported no remaining Halozyme position as of Q1 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 8,494 Halozyme shares in Q1 2019, an estimated $138K.
  • Parallax Volatility Advisers first reported a position in Halozyme in Q1 2017 and held it in 3 quarters.
  • Parallax Volatility Advisers's Halozyme position peaked at $370K in Q4 2017.
  • 201 funds tracked by Wall St. Rank held Halozyme as of Q1 2019.

Based on Parallax Volatility Advisers's 13F filing for Q1 2019, filed 15 May 2019.